Provention Bio

+$0.08 (+1.34%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Provention Bio and other ETFs, options, and stocks.

About PRVB

Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D); PRV-015 for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 for Crohn’s disease; PRV-3279 for the treatment of lupus; and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset.

CEO
Ashleigh W. Palmer
Employees
—
Headquarters
Red Bank, New Jersey
Founded
2016

PRVB Key Statistics

Market Cap
490.46M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.04M
High Today
$6.10
Low Today
$5.72
Open Price
$5.93
Volume
641.85K
52 Week High
$20.05
52 Week Low
$5.59

PRVB Earnings

-$0.58
-$0.30
-$0.02
$0.26
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure